Search: WFRF:(De Marchis F) >
European Stroke Org...
European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease
-
- Psychogios, Marios (author)
- University Hospital Basel
-
- Brehm, Alex (author)
- University Hospital Basel
-
- López-cancio, Elena (author)
- Asturias General Hospital
-
show more...
-
- Marco De Marchis, Gian (author)
- University Hospital Basel,University of Basel
-
- Meseguer, Elena (author)
- Hopital Bichat-Claude-Bernard AP-HP
-
- Katsanos, Aristeidis H (author)
- McMaster University
-
- Kremer, Christine (author)
- Lund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine,Skåne University Hospital
-
- Sporns, Peter (author)
- University Medical Center Hamburg-Eppendorf,University Hospital Basel
-
- Zedde, Marialuisa (author)
- Azienda USL-IRCCS di Reggio Emilia
-
- Kobayashi, Adam (author)
- Cardinal Stefan Wyszyński University in Warsaw,Mazovian voivodeship hospital, Siedlce
-
- Caroff, Jildaz (author)
- Hopital Bichat-Claude-Bernard AP-HP
-
- Bos, Daniel (author)
- Erasmus University Medical Center
-
- Lémeret, Sabrina (author)
- European Stroke Organisation
-
- Lal, Avtar (author)
- European Stroke Organisation
-
- Arenillas, Juan F (author)
- University of Valladolid
-
show less...
-
(creator_code:org_t)
- 2022-06-03
- 2022
- English.
-
In: European Stroke Journal. - : SAGE Publications. - 2396-9881 .- 2396-9873.
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The aim of the present European Stroke Organisation guideline is to provide clinically useful evidence-basedrecommendations on the management of patients with intracranial atherosclerotic disease (ICAD). The guidelines wereprepared following the Standard Operational Procedure of the European Stroke Organisation guidelines and accordingto GRADE methodology. ICAD represents a major cause of ischemic stroke worldwide, and patients affected by thiscondition are exposed to a high risk for future strokes and other major cardiovascular events, despite best medicaltherapy available. We identified 11 relevant clinical problems affecting ICAD patients and formulated the correspondingPopulation Intervention Comparator Outcomes (PICO) questions. The first two questions refer to the asymptomaticstage of the disease, which is being increasingly detected thanks to the routine use of noninvasive vascular imaging. Wewere not able to provide evidence-based recommendations regarding the optimal detection strategy and management ofasymptomatic ICAD, and further research in the field is encouraged as subclinical ICAD may represent a big opportunityto improve primary stroke prevention. The second block of PICOs (3–5) is dedicated to the management of acutelarge vessel occlusion (LVO) ischemic stroke caused by ICAD, a clinical presentation of this disease that is becomingincreasingly relevant and problematic, since it is associated with more refractory endovascular reperfusion procedures.An operational definition of probable ICAD-related LVO is proposed in the guideline. Despite the challenging context,no dedicated randomized clinical trials (RCTs) were identified, and therefore the guideline can only provide withsuggestions derived from observational studies and our expert consensus, such as the escalated use of glycoproteinIIb-IIIa inhibitors and angioplasty/stenting in cases of refractory thrombectomies due to underlying ICAD. The last blockof PICOs is devoted to the secondary prevention of patients with symptomatic ICAD. Moderate-level evidence wasfound to recommend against the use of oral anticoagulation as preferred antithrombotic drug, in favor of antiplatelets.Low-level evidence based our recommendation in favor of double antiplatelet as the antithrombotic treatment of choicein symptomatic ICAD patients, which we suggest to maintain during 90days as per our expert consensus. Endovasculartherapy with intracranial angioplasty and or stenting is not recommended as a treatment of first choice in high-gradesymptomatic ICAD (moderate-level evidence). Regarding neurosurgical interventions, the available evidence does notsupport their use as front line therapies in patients with high-grade ICAD. There is not enough evidence as to provideany specific recommendation regarding the use of remote ischemic conditioning in ICAD patients, and further RCTsare needed to shed light on the utility of this promising therapy. Finally, we dedicate the last PICO to the importanceof aggressive vascular risk factor management in ICAD, although the evidence derived from RCTs specifically addressingthis question is still scarce
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Public Health, Global Health, Social Medicine and Epidemiology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database
- By the author/editor
-
Psychogios, Mari ...
-
Brehm, Alex
-
López-cancio, El ...
-
Marco De Marchis ...
-
Meseguer, Elena
-
Katsanos, Ariste ...
-
show more...
-
Kremer, Christin ...
-
Sporns, Peter
-
Zedde, Marialuis ...
-
Kobayashi, Adam
-
Caroff, Jildaz
-
Bos, Daniel
-
Lémeret, Sabrina
-
Lal, Avtar
-
Arenillas, Juan ...
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Health Sciences
-
and Public Health Gl ...
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
European Stroke ...
- By the university
-
Lund University